CRZBF logo
CRZBF(CRZBF)
$46.10Stale · unknown old
Chart

Fair Value

Price (monthly) Fair value line (dashed = analyst estimates) above fair value below fair value
Undervalued
-39%
vs fair value
Price
$46.1
Fair value
$75.99
Today's multiple
14.8x
Fair value multiple
24.5x
Typical multiple, 20y
13.1x
Adjusted EPS growth rate
24.5%
Trailing 12M adjusted EPS
$3.11

Results are highly cyclical for CRZBF, so multiple-based fair value is less reliable here.

FY201320142015201620172018201920202022202320252026E2027E2028E2029E2030E
High22.2019.3014.2810.0115.3116.709.037.3010.5212.5044.76
Low7.9113.2010.085.927.456.305.203.126.059.5015.45
Adj EPS-0.020.350.920.240.870.780.68-0.651.142.022.903.19E3.88E4.66E5.08E6.30E
Chg/Yr+164%-74%+258%-10%-14%-196%+77%+44%+10%+22%+20%+9%+24%
Div0.000.000.000.230.000.000.220.200.000.220.73
How these numbers are calculated

Fair value (24.5x) multiplies each year's earnings per share by a growth-based multiple: steady growers (5–15% a year) get 15x, faster growers get their growth rate as the multiple (capped at 30x), and slower growers step down below 15x. CRZBF has grown earnings about 24.5% a year, so the line uses 24.5x.

Typical multiple (13.1x) is what investors have actually paid for CRZBF: each of the last 20 fiscal years' average share price divided by that year's earnings per share, taking the median (loss years excluded). It shows how the market has historically priced this specific company, next to the general fair-value rule.

Today's multiple (14.8x) is what the market is paying right now: the current price divided by the last twelve months of earnings (the four most recent reported quarters). Compare it to the two reference multiples above to see whether today's pricing is rich or cheap.

Earnings are adjusted figures on the same basis analysts forecast, built from reported quarters; years beyond the last completed fiscal year use the analyst consensus (dashed). The verdict calls a stock over- or undervalued only when the price sits more than 10% from the fair value line.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.